Profile
Ms. Hema Keshava is a Senior Vice President-Finance at Abivax SA and a Corporate Controller at CinCor Pharma, Inc.
Hema Keshava active positions
| Companies | Position | Start |
|---|---|---|
| CINCOR PHARMA, INC. | Comptroller/Controller/Auditor | 2021-10-31 |
| ABIVAX | Corporate Officer/Principal | 2023-06-30 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ABIVAX | Health Technology |
| Private companies | 1 |
|---|---|
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Hema Keshava
